Objective Evaluate, in vivo, the biocompatibility via subcutaneous inflammatory tissue response and mineralization ability of the new MTA Flow compared to MTA Angelus and ProRoot MTA. Materials and methods Forty male Wistar rats were assigned and received subcutaneous polyethylene tube implants containing the test materials and a control group with empty tube (n = 10 animals/group). After days 7, 15, 30, and 60, the animals were euthanized and the polyethylene tubes were removed with the surrounding tissues. Inflammatory infiltrate and thickness of the fibrous capsule were histologically evaluated. Mineralization was analyzed by Von Kossa staining and under polarized light. Data were analyzed via Kruskal-Wallis and Dunn's test with a significance level of 5%. Results MTA Angelus induced the mildest reaction after 7 (P > .05) and 15 days (P < .05) followed by MTA Flow, both cements achieving mild inflammatory reaction after 15 days. ProRoot MTA induced a severe inflammation on day 7 and was reducing after day 15 (P > .05). No difference was observed after days 30 or 60 (P > .05). Von Kossa staining and birefringent structures were positive to all materials. Conclusions At the end of the experiment, the novel MTA Flow showed biocompatibility and induced biomineralization in all time periods. Clinical relevance The final consistence obtained in MTA Flow may facilitate several procedures, indicating that the MTA Flow has a promising application in endodontics.
Introduction
Biocompatibility and capacity to induce biomineralized tissue formation are important requirements for sealing materials that will be in contact with tissue [1] .
The biocompatibility evaluation in rat model may be assessed by different methodologies such as pulpotomy [2] , subcutaneous implantation [3] , cell viability [4] , or even in dental alveolus [5] . The implantation of these materials into the subcutaneous tissue of rats is considered a standardized [6] , common, and valid test for biocompatibility [7] , analyzing the inflammatory tissue response through HE staining [3-5, 8, 9] within time periods of the recommended standard practices for biological evaluation of dental materials [10] .
The mineral trioxide aggregate (MTA), a Portland cementderived calcium silicate-based hydraulic material [11] , was developed to seal communication between teeth and the periodontium, in pathologic or iatrogenic root perforations [12, 13] . Numerous studies confirmed its effectiveness as a biocompatible material, inducing the formation of mineralized tissue, besides the antimicrobial activity. These excellent biological properties are attributed to its alkaline pH and calcium ion release capacity, maintaining a high pH [14] [15] [16] . The hydrophilic nature of the MTA particles allows its use even in the presence of moisture, once the main components are tricalcium and dicalcium silicate, tricalcium aluminate, tricalcium oxide, and radiopacifying agents, such as bismuth oxide [17] .
MTA Angelus (Angelus Indústria de Produtos Odontológicos S/A, Londrina, PR, Brazil) and ProRoot MTA (Tulsa Dental Products, Tulsa, OK, USA) are MTA cements with proven biological and physical-chemical properties, both known for their favorable tissue response and capability of forming mineralized tissue [8, 18] .
However, the poor working properties of MTA-like cements results in a paste hard to manipulate and to deliver [19] . Considering the importance of the ideal flow ability that endodontic cements should present reducing the difficulty of handling [20] , high plasticity cements were developed with the aim of improving these characteristic.
Recently released, the MTA Flow (Ultradent Products Inc., South Jordan, UT) consists of a gray powder of di-and tricalcium silicate, bismuth oxide as radiopacifier, and a liquid vehicle composed of a water soluble silicone-based gel [21] . According to the manufacturer, the gel provides a higher plasticity, improving handling and its insertion, which may facilitate the use in various procedures: a thick consistency for pulp capping, pulp chamber perforation, and pulpotomy; a thin consistency for resorption, apexification, and apical plug; or a putty consistency for root end filling [22] . The manufacturer also claims that unlike other MTA cements, which use water and have a coarse sandy consistency, MTA Flow cement has a creamy and homogeneous characteristic after mixing. The presentation of this material seems to be innovative in relation to the other cements available. However, as a new cement, there are no published studies concerning its biological properties or ability to induce the formation of hard tissue.
Therefore, the aim of the present study was to evaluate MTA Flow, analyzing the in vivo reaction of subcutaneous tissue of rats, and its ability to induce mineralization, assessed by von Kossa staining and presence of structures birefringent under polarized light. MTA Angelus and ProRoot MTA were used for comparison.
Materials and methods
This study was approved by the institutional Ethics Committee on the Use of Animals at UNESP-Universidade Estadual Paulista (São Paulo, Brazil) and conducted in accordance with relevant guidelines (CEUA protocol 00225-2017).
In vivo study
Subcutaneous implant Forty male 4 to 6-month-old Wistar rats, weighing 250-280 g, were used in the study. The animal sample size was based on previous studies that used the same methodology to assess biocompatibility and biomineralization in subcutaneous tissue of rats [3-5, 8, 23] . The animals were housed in temperature-controlled rooms and were provided with water and food ad libitum.
One hundred and sixty polyethylene tubes (Abbott Laboratories of Brazil, Sao Paulo, SP, Brazil) were prepared according to previous studies [8, 24] and filled with the tested cements. ProRoot MTA and MTA Angelus were spatulated according to the manufacturer's specification and inserted into the tubes with the aid of a lentullo spiral. MTA Flow was manipulated and inserted into a proper syringe and directly inserted into the polyethylene tubes. Therefore, all polyethylene tubes were completely filled, standardizing the same amount of cement for all experimental groups. Forty extra polyethylene empty tubes were used as controls, totaling 160 tubes in the experiment.
The surgical procedure was performed following previous studies [3, 8, 23, 24] . After administration of xylazine (10 mg/ kg Rhobifarma Indústria Farmacêutica Ltda, Hortolândia, Brazil) and ketamine (25 mg/kg União Química Farmacêutica Nacional S/A, São Paulo, Brazil) intramuscular anesthesias, the backs of the animals were shaved, antisepsis was obtained with 5% iodine solution, and a 2-cm incision was formed in a head-tail orientation with no. After 7, 15, 30, and 60 days, the animals were killed by an anesthetic overdose. Polyethylene tubes, with the surrounding tissues, were removed and fixed in 10% formalin solution at a pH 7.0. The fixed specimens were processed and embedded in paraffin and serially sectioned into 5-μm cuts for staining with hematoxylin-eosin and 10-μm cuts for staining with the von Kossa technique, used to observe mineralization as it darkly stains mineralized structures. Some slices were kept unstained for examination under polarized light to observe the presence of birefringent structures (Graph 1).
Histologic analysis was performed by a single calibrated operator in a blinded manner under × 400 light microscopy (DM 4000 B; Leica, Wetzlar, Germany). Tissue reactions at the open end of the tubes were scored according to previous studies [3-5, 8, 23] as follows: 0, few inflammatory cells or no reaction; 1, less than 25 cells and mild reaction; 2, between 25 and 125 inflammatory cells and moderate reaction; and 3, 125 or more inflammatory cells and severe reaction. Fibrous capsules were considered thin when < 150 μm and thick when > 150 μm, as exemplified in Fig. 1 . The Hematoxylin-Eosin staining allowed the evaluation of the contact area between the subcutaneous tissue and the tested material (at the lower center of the polyethylene tube) and one of the scores was attributed, classifying the tissue response as mild, moderate, or severe for each experimental time period of 7, 15, 30, and 60 days.
Calcification was recorded as positive or negative by Von Kossa staining and present or absent under PL [3, 8] .
Statistical analysis Data were submitted to statistical analysis using the Sigma Plot (version 12.0, Systat Software Inc., CA) software program. The Kruskal-Wallis test followed by the Dunn test was performed for the nonparametric data; P < .05 was considered significant.
Results

The control group
A moderate chronic inflammatory infiltrate (median score 2) was observed at the first two experimental periods (Table 1) , on days 7 and 15 ( Fig. 2(A,a, B,b) ). The inflammatory reaction, with lymphocytes and macrophages, was present in the thick fibrous capsule. After 30 and 60 days (Fig. 2(C,c, D,d) ), the fibrous capsule became thin, with few inflammatory cells (median score 1). The mineralization was negative for Von Kossa and no birefringent structures were present under PL at all time periods, as observed in Table 2 and Fig. 3(A,a-D,d ).
Graph 1 Study graphical outline, showing the experiment protocol at day 0 (subcutaneous implantation), days 7, 15, 30, and 60 (euthanasia, followed by the laboratory process: tube removal with surrounding tissue and paraffin embedding), samples staining and microscopy analysis. 
MTA Angelus
The inflammatory infiltrate was considered moderate after 7 days (median score 2) and reduced to a mild inflammation (median score 1) from day 15 (P < .05) to 60, as observed in Fig. 2(E,e-H,h) and Table 1 . The fibrous capsule near the tube opening was thick only on day 7 ( Fig.  2(E,e) ) and became thin after 15 days and continued until the end of the experimental time periods (Fig. 2(F,f-H,h) ). Granulations birefringent to PL and Von Kossa-positive staining were observed near the tube opening at all time periods (Fig. 3(E,e-H,h) and Table 2 ).
MTA Flow
Only on day 7, a moderate inflammatory cell infiltration (median score 2), comprising lymphocytes and macrophages, was present in the thick fibrous capsule (Fig. 2(I,i) ; Table 1 ). After 15, 30, and 60 days, the intensity of the inflammation was reduced (median score 1; P > .05) and the fibrous capsule was thin, similar to the control group (Fig. 2(J,j-L,l) . The presence of granulations birefringent under PL and Von Kossa-positive stains was observed in all time periods (Fig.  3(I,i-L,l) and Table 2 ).
ProRoot MTA
Although a severe inflammatory infiltrate was observed (median score 3) after 7 days (P > .05), it was notable that almost half of the specimens achieved a moderate and mild inflammation (median score 2 and 1, respectively), both in a thick fibrous capsule (Fig. 2(M,m) and Table 1 ). After 15 days, the inflammation was reduced (median score 2) but the fibrous capsule remained thick (Table 1) . Only after 30 and 60 days, the inflammatory infiltrate was considered mild (median score 1; P > .05) and with a thin fibrous capsule in both periods (Fig.  2(O,o, P,p) and Table 1 ), same result as the control group. The biomineralization ability was observed in all time periods, with structures darkly stained by the Von Kossa technique and the presence of birefringent structures under PL was also observed (Fig. 3(M,m-P,p) and Table 2 ).
Comparison among groups
Data were compared for each time period (Tables 1 and 2 ). After 7 days, the control group showed a median score 2, with a thick fibrous capsule. ProRoot MTA showed a severe inflammation (median score 3) after 7 days, with a thick fibrous capsule. After 15 days, it was possible to observe a reduction on the inflammatory infiltrate regarding MTA Angelus (P < .05) and MTA Flow, which induced a mild inflammation (median score 1) in a thin fibrous capsule. The control group remained with a thick fibrous capsule and the moderate inflammation after 15 days, same result as the ProRoot MTA. After 30 and 60 days, all groups presented a mild inflammatory infiltrate (median score 1), restricted to a thin fibrous capsule, without statistical difference (P > .05).
Regarding the biomineralization, with exception of the control group, all cements induced the formation of mineralized tissue in all experimental periods, confirmed by the presence of structures darkly stained by the Von Kossa technique (Fig. 3(A-P) ; Table 2 ) and the birefringent structures observed under polarized light (Fig. 3(a-p) ; Table 2 ). 
Discussion
This research showed the MTA Flow was biocompatible and induced biomineralization, as well as the MTA Angelus and the ProRoot MTA. According to the American Association of Endodontists, a new material should be biologically and clinically studied before its use [25] , since materials that will be in close contact with the periapical tissues should exhibit biocompatibility and the ability to induce the formation of mineralized tissue [26] . The rat model for subcutaneous implantation is widely used as one of the pre-clinical research tests for biocompatibility, when facing new materials [6, 7, 27] . The choice of using MTA Angelus and the ProRoot MTA as a positive control was due to several studies concerning biocompatibility and biomineralization. In the present study, the groups showed a moderate initial inflammatory response, reducing over time as the fibrous capsule became thin, corroborating previous findings [9, 24, [28] [29] [30] [31] . This initial inflammatory reaction is due to the surgical procedure, and the normal reaction form the tissue when facing a subcutaneous implant, as well as for the MTA Angelus and the MTA Flow group. It is normal to observe an initial inflammatory reaction when using MTA-like cements, because the alkalinity damage provoked on tissues but it is also important to state that the biocompatibility of a material is achieved if the initial inflammatory reaction reduces over time, to a not significant level [32, 33] .
The biocompatibility and bioactivity of MTA begins with its setting reaction. The hydration of mineral oxide compounds produces calcium silicate hydrate and calcium hydroxide, which after dissociation, continuously releases Ca ions, providing a high alkalinity environment and inducing the formation of mineralized tissue [34] . The ions Ca, originating from the MTA dissociation, interacts with P ions in body fluids resulting in the formation of calcium phosphate crystalline structures on the materials' interfacial surfaces, which is an amorphous form of calcium phosphate and/or carbonate apatite [35] [36] [37] [38] .
The earliest MTA cements exhibited a difficult handling and consequently difficult delivering [39] leading to the constant search of new formulations to improve flowability, combining enhanced handling, mechanical and biological properties [40, 41] . This innovation in the vehicle used to achieve a higher plasticity type of MTA has been recently studied, showing biocompatibility and inducing biomineralization [8] .
A recent study regarding the chemical-physical properties and the apatite-forming ability of the MTA Flow reported alkalinizing capability, low solubility, good radiopacity and the ability to form calcium phosphate deposits [42] . Until now, there are no studies in the literature concerning the biological properties of the MTA Flow. The manufacturer claims that this novel MTA-repair cement combined with the water silicone-based gel improves the handling of the cement and can be adapted depending on the procedure, since after mixing, the MTA Flow achieves a consistency that passes through a syringe, facilitating insertion [22] .
Previous reports that used the implantation of bioactive materials in subcutaneous tissue of rats described the formation of a mineralized layer, darkly stained by the Von Kossa technique [3, 34] . In the present study, the biomineralization ability of MTA Flow was detected by the presence of structures birefringent to polarized light and von Kossa-positive staining, also observed in the MTA Angelus and ProRoot MTA. According to Hinata [11] , the presence of Von Kossapositive structures is in accordance with a production of Ca and P surface precipitates and a Ca-and P-rich layer at the interface between material and tissue, supporting the ability of calcium silicate-based materials to promote biomineralization after contact with connective tissue. Reinforcing these findings, Guimaraes et al. [42] reported through an energydispersive X-ray (EDX) analysis that the calcium (Ca) and phosporous (P) ratios of MTA Flow were higher in Another important factor observed in our laboratory experience was the different consistency between the types of MTA used in the study during the mixing. Although the particle size was not analyzed in this research, the granulations in MTA Angelus and ProRoot MTA were apparently more thick, hindering the cement handling, while the MTA Flow showed a thinner composition of the powder, which, in addition of the water-based gel, facilitated the procedure, corroborating previous findings [42] . The manufacturer claims that the smooth consistency achieved with MTA Flow cement is due not only to the proprietary gel medium, but mainly also to the ultrafinefined powder, which differs from others MTA cements available in the market [22] . The potential influence of particle size might increase the reactivity of the dicalcium and tricalcium silicate particles, since the geometry of small MTA particles enables entering into open dentin tubules, which could be an important mechanism to enhance the sealing ability and even improving the handling of MTA-like cements [43] .
Within the limits of this study in the rat model, the novel MTA Flow showed biocompatibility and the ability to form biomineralizated tissue, representing an alternative to the conventional MTA, with a final consistency that could facilitate its clinical use. Since this is the first study evaluating biological properties, additional research is necessary to confirm the present findings.
